260 related articles for article (PubMed ID: 33125586)
1. Inhibition of transient receptor potential vanilloid 1 (TRPV1) channel regulates chikungunya virus infection in macrophages.
Sanjai Kumar P; Nayak TK; Mahish C; Sahoo SS; Radhakrishnan A; De S; Datey A; Sahu RP; Goswami C; Chattopadhyay S; Chattopadhyay S
Arch Virol; 2021 Jan; 166(1):139-155. PubMed ID: 33125586
[TBL] [Abstract][Full Text] [Related]
2. P38 and JNK Mitogen-Activated Protein Kinases Interact With Chikungunya Virus Non-structural Protein-2 and Regulate TNF Induction During Viral Infection in Macrophages.
Nayak TK; Mamidi P; Sahoo SS; Kumar PS; Mahish C; Chatterjee S; Subudhi BB; Chattopadhyay S; Chattopadhyay S
Front Immunol; 2019; 10():786. PubMed ID: 31031770
[TBL] [Abstract][Full Text] [Related]
3. Activity of andrographolide against chikungunya virus infection.
Wintachai P; Kaur P; Lee RC; Ramphan S; Kuadkitkan A; Wikan N; Ubol S; Roytrakul S; Chu JJ; Smith DR
Sci Rep; 2015 Sep; 5():14179. PubMed ID: 26384169
[TBL] [Abstract][Full Text] [Related]
4. TLR4 is one of the receptors for Chikungunya virus envelope protein E2 and regulates virus induced pro-inflammatory responses in host macrophages.
Mahish C; De S; Chatterjee S; Ghosh S; Keshry SS; Mukherjee T; Khamaru S; Tung KS; Subudhi BB; Chattopadhyay S; Chattopadhyay S
Front Immunol; 2023; 14():1139808. PubMed ID: 37153546
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Viral Replication, Apoptosis and Pro-Inflammatory Responses by 17-AAG during Chikungunya Virus Infection in Macrophages.
Nayak TK; Mamidi P; Kumar A; Singh LP; Sahoo SS; Chattopadhyay S; Chattopadhyay S
Viruses; 2017 Jan; 9(1):. PubMed ID: 28067803
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of nobiletin against chikungunya virus in vitro.
Lin SC; Chen MC; Li S; Lin CC; Wang TT
Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
mBio; 2016 May; 7(3):. PubMed ID: 27222471
[TBL] [Abstract][Full Text] [Related]
9. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
Varghese FS; Thaa B; Amrun SN; Simarmata D; Rausalu K; Nyman TA; Merits A; McInerney GM; Ng LFP; Ahola T
J Virol; 2016 Nov; 90(21):9743-9757. PubMed ID: 27535052
[TBL] [Abstract][Full Text] [Related]
10. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
[TBL] [Abstract][Full Text] [Related]
11. Current Strategies for Inhibition of Chikungunya Infection.
Subudhi BB; Chattopadhyay S; Mishra P; Kumar A
Viruses; 2018 May; 10(5):. PubMed ID: 29751486
[TBL] [Abstract][Full Text] [Related]
12. Antiviral Strategies Against Chikungunya Virus.
Abdelnabi R; Neyts J; Delang L
Methods Mol Biol; 2016; 1426():243-53. PubMed ID: 27233277
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D modulates the expression of Toll-like receptors and pro-inflammatory cytokines without affecting Chikungunya virus replication, in monocytes and macrophages.
Valdés-López JF; Velilla P; Urcuqui-Inchima S
Acta Trop; 2022 Aug; 232():106497. PubMed ID: 35508271
[TBL] [Abstract][Full Text] [Related]
14. Antiviral therapeutics for chikungunya virus.
Ghildiyal R; Gabrani R
Expert Opin Ther Pat; 2020 Jun; 30(6):467-480. PubMed ID: 32249636
[No Abstract] [Full Text] [Related]
15. Antivirals against the Chikungunya Virus.
Battisti V; Urban E; Langer T
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372513
[TBL] [Abstract][Full Text] [Related]
16. Chikungunya virus infection induces differential inflammatory and antiviral responses in human monocytes and monocyte-derived macrophages.
Felipe VLJ; Paula A V; Silvio UI
Acta Trop; 2020 Nov; 211():105619. PubMed ID: 32634389
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
[TBL] [Abstract][Full Text] [Related]
18. Chikungunya virus infections: time to act, time to treat.
Abdelnabi R; Neyts J; Delang L
Curr Opin Virol; 2017 Jun; 24():25-30. PubMed ID: 28414993
[TBL] [Abstract][Full Text] [Related]
19. Andrographolide Mitigates Unfolded Protein Response Pathway and Apoptosis Involved in Chikungunya Virus Infection.
Gupta S; Mishra KP; Kumar B; Singh SB; Ganju L
Comb Chem High Throughput Screen; 2021; 24(6):849-859. PubMed ID: 32819227
[TBL] [Abstract][Full Text] [Related]
20. Beyond Members of the
Ferreira AC; Reis PA; de Freitas CS; Sacramento CQ; Villas Bôas Hoelz L; Bastos MM; Mattos M; Rocha N; Gomes de Azevedo Quintanilha I; da Silva Gouveia Pedrosa C; Rocha Quintino Souza L; Correia Loiola E; Trindade P; Rangel Vieira Y; Barbosa-Lima G; de Castro Faria Neto HC; Boechat N; Rehen SK; Brüning K; Bozza FA; Bozza PT; Souza TML
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
